4.7 Review

Humanized mouse models of genetic immune disorders and hematological malignancies

期刊

BIOCHEMICAL PHARMACOLOGY
卷 174, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2019.113671

关键词

Immune; Humanized; Mouse; Monogenic; Immunotherapy

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases [DK106311]
  2. Academy Ter Meulen Grant from the Royal Netherlands Academy of Arts and Sciences
  3. Cultural Foundation Grant from Prince Bernhard Cultural Foundation
  4. joint Israel-US Binational Science Foundation (BSF) grant

向作者/读者索取更多资源

The immune system is quite remarkable having both the ability to tolerate innocuous and self-antigens while possessing a robust capacity to recognize and eradicate infectious pathogens and foreign entities. The genetics that encode this delicate balancing act include multiple genes and specialized cell types. Over the past several years, whole exome and whole genome sequencing has uncovered the genetics driving many human immune-mediated diseases including monogenic disorders and hematological malignancies. With the advent of genome editing technologies, the ability to correct genetic immune defects in autologous cells holds great promise for a number of conditions. Since assessment of novel therapeutic strategies have been difficult in mice, in recent years, immunodeficient mice capable of engrafting human cells and tissue have been developed and utilized for a variety of research applications. In this review, we discuss immune-humanized mice as a research tool to study human immunobiology and genetic immune disorders in vivo and the promise of future applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据